Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral alendronate versus intravenous pamidronate for osteopenia and osteoporosis in children
IRCT20211121053122N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial in osteopenia and osteoporosis comparing Oral alendronate with Intravenous pamidronate (2 arms). Primary endpoint: Bone mineral density. Started Nov 2021; status: completed.
02
Drugs
alendronatepamidronate
03
Conditions
osteopeniaosteoporosis
Beyond the preview
Go deeper on IRCT20211121053122N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211121053122N1.